Connect with us
Pennsylvania recorded a fifth measles death on September 30, while CDC’s dashboard still lists two as a count fight stalls...
Elecsys pTau217 is cleared for adults 55 and older, but a positive or intermediate Alzheimer's blood test still needs backup.
AstraZeneca’s Wainua miss lets stabilizer drugs claim first-line ATTR-CM care as Alnylam defends Amvuttra’s trial design.
AstraZeneca’s Wainua missed its ATTR-CM endpoint, and the 1.14 combo ratio cements oral stabilizer pills as first-line care over gene silencers.
Rural patients lose Medicaid coverage and local hospital services under $1.1 trillion in tax-law health cuts a $50 billion rural fund does not offset.
474 Salmonella cases and two deaths are running through imported eggs in cafes, not Lion-marked shop eggs, and tracing that catering channel is taking weeks.
Prestige is pulling 39,060 Clear Eyes Maximum Itchy Eye Relief bottles, the same sterility-assurance gap that hit the brand in 2019.
NHS boards face ADHD and autism invoices from £300 to £3,000, while GPs can refuse shared care and local lists still hold hundreds of thousands.
Four XFG COVID-19 vaccines can ship after FDA approval, yet a frozen CDC panel leaves coverage and pharmacy access unsettled for high-risk patients.
Two Lancaster measles-associated deaths set off a fight with HHS, but kindergarten MMR coverage of 92.4 percent is the number that outlasts the argument.
England is offering HPV home testing kits to nearly 4 million under-screened women, copying a model Australia, the Netherlands and Sweden have already measured.
